Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapyMelody Smith, Marco Ruella, Anqi Dai et al.|Nature Medicine|2022Cited by 308
Hematopoietic recovery in patients receiving chimeric antigen receptor T-cell therapy for hematologic malignanciesTania Jain, Sham Mailankody, Andrea Knežević et al.|Blood Advances|2020Cited by 264
Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation: A Report on Behalf of the American Society for Transplantation and Cellular TherapyMohamed A. Kharfan‐Dabaja, Marcie Riches, Sonali Chaudhury et al.|Transplantation and Cellular Therapy|2021Cited by 180
Best Practice Considerations by The American Society of Transplant and Cellular Therapy: Infection Prevention and Management After Chimeric Antigen Receptor T Cell Therapy for Hematological MalignanciesZainab Shahid, Joshua A. Hill, Tania Jain et al.|Transplantation and Cellular Therapy|2024Cited by 78
Comparison of reduced intensity conditioning regimens used in patients undergoing hematopoietic stem cell transplantation for myelofibrosisTania Jain, Jeanne Palmer, Katie L. Kunze et al.|Bone Marrow Transplantation|2018Cited by 46